FDA.reportPublic FDA data

empagliflozin 25 MG / linagliptin 5 MG Oral Tablet

RxCUI
1602118
RxNorm name
empagliflozin 25 MG / linagliptin 5 MG Oral Tablet
Display name
empagliflozin 25 MG / linagliptin 5 MG Oral Tablet
Full name
empagliflozin 25 MG / linagliptin 5 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GlyxambiEMPAGLIFLOZIN AND LINAGLIPTINBoehringer Ingelheim Pharmaceuticals, Inc.ddbab689-f76c-488c-9613-4168d41dd7302026-01-20Warnings, Adverse reactionsExact identifier
rxcui: 1602118

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ddbab689-f76c-488c-9613-4168d41dd730empagliflozin 25 MG / linagliptin 5 MG Oral TabletSCD23These highlights do not include all the information needed to use GLYXAMBI safely and effectively. See full prescribing information for GLYXAMBI. GLYXAMBI ® (empagliflozin and linagliptin tablets), for oral use Initial U.S. Approval: 201520260120
ddbab689-f76c-488c-9613-4168d41dd730empagliflozin 25 MG / linagliptin 5 MG Oral TabletPSN23These highlights do not include all the information needed to use GLYXAMBI safely and effectively. See full prescribing information for GLYXAMBI. GLYXAMBI ® (empagliflozin and linagliptin tablets), for oral use Initial U.S. Approval: 201520260120